"Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Photo by fusion_medical_animation from unsplash

This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications. Click to show full abstract

This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications.

Keywords: reevaluating liver; hepatitis virus; risk; liver donor; donor risk

Journal Title: JAMA surgery
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
2

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended